Fig. 2From: Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?Plasma urea and creatinine levels. Urea and creatinine levels (mean ± standard deviation) determined before the start of gadolinium-based contrast agent administration (day -4), immediately after the end of dosing (day 32) and at scheduled sacrifices: 28 days post-treatment (day 53, a, b) or 56 days post-treatment (day 81, c, d). The error bars represent the standard deviation of measurements within the groups (group 1, gadoteridol, n = 8 in a to d; group 2, gadobutrol, n = 8 in a and b, n = 7 in c and d; group 3, gadoterate, n = 9 in a and b, n = 8 in c and d; group 4, gadoteridol, n = 5 in a to d)Back to article page